ReleaseWire Connect

Summary

GlobalData has released its new PharmaPoint Drug Evaluation report, Vectibix (Colorectal Cancer) - Forecast and Market Analysis to 2023. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus represents a huge burden on healthcare systems.

GlobalData has released its new PharmaPoint Drug Evaluation report, Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus represents a huge burden on healthcare systems.

Nuclear Power in Canada, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the nuclear power market in Canada.

GlobalData's clinical trial report, HIV-1 Infection Global Clinical Trials Review, H2, 2014" provides data on the HIV-1 Infection clinical trial scenario. This report provides elemental information and data relating to the clinical trials on HIV-1 Infection.

GlobalData's clinical trial report, Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2014" provides data on the Hand, Foot And Mouth Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hand, Foot And Mouth Disease.

Synopsis

Synopsis

This report provides the latest asset allocations of Colombia HNWIs across 13 asset classes. The report also includes projections of the volume, wealth and asset allocations of Colombia HNWIs to 2018 and a comprehensive and robust background of the local economy.

This report reviews the performance and asset allocations of Ultra HNWIs in Colombia, and highlights top-performing cities. It also includes an evaluation of the local wealth management industry.